drugset / Trial / NCT05863104
Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study is to evaluate the safety, tolerability and systemic exposure (in a subset of patients) of topical administration of 1% GPB in adolescents with severe primary axillary hyperhidrosis.
Timeline
- Start
- 2023-03-07
- Primary completion
- 2024-03-06
- Completion
- 2024-03-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrronium | Unknown | 1 % | Topical |